These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3992472)

  • 21. Limits on optimizing ocular drug delivery.
    Keister JC; Cooper ER; Missel PJ; Lang JC; Hager DF
    J Pharm Sci; 1991 Jan; 80(1):50-3. PubMed ID: 2013850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Corneal penetration and ocular bioavailability of drugs.
    Burstein NL; Anderson JA
    J Ocul Pharmacol; 1985; 1(3):309-26. PubMed ID: 3916851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving the ocular to systemic ratio of topical timolol by varying the dosing time.
    Ohdo S; Grass GM; Lee VH
    Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2790-8. PubMed ID: 1894477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the ocular distribution of a model oligonucleotide after topical instillation in rabbits of conventional and new dosage forms.
    Bochot A; Mashhour B; Puisieux F; Couvreur P; Fattal E
    J Drug Target; 1998; 6(4):309-13. PubMed ID: 9894698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fabrication and characterization of silk fibroin-coated liposomes for ocular drug delivery.
    Dong Y; Dong P; Huang D; Mei L; Xia Y; Wang Z; Pan X; Li G; Wu C
    Eur J Pharm Biopharm; 2015 Apr; 91():82-90. PubMed ID: 25643990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advance of the application of nano-controlled release system in ophthalmic drug delivery.
    Wang X; Wang S; Zhang Y
    Drug Deliv; 2016 Oct; 23(8):2897-2901. PubMed ID: 26635087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery.
    Jiao J
    Adv Drug Deliv Rev; 2008 Dec; 60(15):1663-73. PubMed ID: 18845195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of lipid peroxidation and electron microscopic survey of maturation stages during human cataractogenesis: pharmacokinetic assay of Can-C N-acetylcarnosine prodrug lubricant eye drops for cataract prevention.
    Babizhayev MA
    Drugs R D; 2005; 6(6):345-69. PubMed ID: 16274259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances and limitations of drug delivery systems formulated as eye drops.
    Jumelle C; Gholizadeh S; Annabi N; Dana R
    J Control Release; 2020 May; 321():1-22. PubMed ID: 32027938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs.
    Souto EB; Doktorovova S; Gonzalez-Mira E; Egea MA; Garcia ML
    Curr Eye Res; 2010 Jul; 35(7):537-52. PubMed ID: 20597640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ocular bioavailability and systemic loss of topically applied ophthalmic drugs.
    Patton TF; Francoeur M
    Am J Ophthalmol; 1978 Feb; 85(2):225-9. PubMed ID: 623195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gelatin-based membrane containing usnic acid-loaded liposomes: A new treatment strategy for corneal healing.
    da Silva FR; Silva RO; de Castro Oliveira HM; Nunes Dourado LF; da Costa BL; Lima BS; Lima Santos NG; Palanch Repeke CE; Menezes GB; de Souza Araújo AA; da Silva-Cunha A; Nunes PS
    Biomed Pharmacother; 2020 Oct; 130():110391. PubMed ID: 32674015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ocular pharmacokinetics and availability of topically applied baicalein in rabbits.
    Zhang L; Zhang J; Wang L; Xia H
    Curr Eye Res; 2009 Apr; 34(4):257-63. PubMed ID: 19373573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel drug delivery systems for ocular therapy: With special reference to liposomal ocular delivery.
    Bhattacharjee A; Das PJ; Adhikari P; Marbaniang D; Pal P; Ray S; Mazumder B
    Eur J Ophthalmol; 2019 Jan; 29(1):113-126. PubMed ID: 29756507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aqueous formulations and ointments.
    MacKeen DL
    Int Ophthalmol Clin; 1980; 20(3):79-92. PubMed ID: 6998903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyalugel-integrated liposomes as a novel ocular nanosized delivery system of fluconazole with promising prolonged effect.
    Moustafa MA; Elnaggar YSR; El-Refaie WM; Abdallah OY
    Int J Pharm; 2017 Dec; 534(1-2):14-24. PubMed ID: 28987453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New directions in the optimization of ocular drug delivery.
    Lee VH
    J Ocul Pharmacol; 1990; 6(2):157-64. PubMed ID: 2203851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ocular absorption of topically applied FK506 from liposomal and oil formulations in the rabbit eye.
    Pleyer U; Lutz S; Jusko WJ; Nguyen KD; Narawane M; Rückert D; Mondino BJ; Lee VH; Nguyen K
    Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2737-42. PubMed ID: 7688360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ways to improve ocular bioavailability for topical applications].
    Sirbat D; Marchal-Heussler L; Hoffman M; Maincent P
    J Fr Ophtalmol; 2000 May; 23(5):505-9; quiz 523. PubMed ID: 10844314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colloidal carriers for ophthalmic drug delivery.
    Mainardes RM; Urban MC; Cinto PO; Khalil NM; Chaud MV; Evangelista RC; Gremiao MP
    Curr Drug Targets; 2005 May; 6(3):363-71. PubMed ID: 15857294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.